Workplace support after breast cancer treatment: recognition of vulnerability

Abstract

Background: Support from the workplace seems to be a key element in addressing the poor return-to-work (RTW) rate of employees with breast cancer. We aim to acquire an in-depth understanding of how Flemish employees experience their RTW after breast cancer and the support from the workplace. Method: Fourteen in-depth interviews of women who experienced breast cancer and returned to work (high school graduates, age range 42–55 years, mean age 48 at time of surgery) were analysed using the Qualitative Analysis Guide of Leuven (QUAGOL), based on a Grounded Theory approach. Results: The key experiences were feeling vulnerable, feeling able to work and need for support. Although little diversity in RTW experiences was found, the background of the vulnerability varied. Women experienced support (which could be emotional or practical) only as adequate if it addressed their specific vulnerability. Conclusions: Employees felt particularly vulnerable. Vulnerability is not the same as low-work ability and as such it should be added as theoretical concept in RTW research. Adequate workplace support addresses the specific vulnerability of an individual woman. Our study offers a nuanced insight into the RTW process of breast cancer survivors.

Implications for Rehabilitation

• Upon actual return-to-work (RTW) after breast cancer treatment, women feel vulnerable but able to work and, hence, have a high need for workplace support.

• Support from the workplace during RTW after breast cancer treatment is experienced as adequate when it expresses genuine recognition of the individual woman’s vulnerability.

• Breast cancer
• return to work
• support
• vulnerability
• work ability

Acknowledgements

We extend a word of thanks to the participants interviewed for this study for their assistance with this project, their trust and openness.

Declaration of interest

The study was funded by the Flemish Cancer League (VLK), Brussels, Belgium. The authors indicated no potential conflicts of interest. We would like to express our thanks to the VLK (Flemish Cancer League) for granting the study.